ArticleJournal of gastroenterology2019

Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver mice.

Akira Doi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.